Comparing disease screening tests when true disease status is ascertained only for screen positives
From MaRDI portal
Publication:5701255
Recommendations
- A Novel Design for Estimating Relative Accuracy of Screening Tests When Complete Disease Verification Is Not Feasible
- Comparing Accuracies of Two Screening Tests in a Two-Phase Study for Dementia
- scientific article; zbMATH DE number 1556440
- Treatment comparisons with screenable endpoints.
- Comparing accuracy in an unpaired post-market device study with incomplete disease assessment
Cited in
(10)- Extending Hui-Walter framework to correlated outcomes with application to diagnosis tests of an eye disease among premature infants
- Comparing the accuracy of screening tests with verification of disease status restricted to test positives
- Some issues concerning the statistical evaluation of a screening test: the arfi ultrasound case
- Covariate-adjusted Bayesian estimation of the performance of a continuous diagnostic test with a limit of detection in the absence of a reference standard: a simulation study
- Comparing accuracy in an unpaired post-market device study with incomplete disease assessment
- A Novel Design for Estimating Relative Accuracy of Screening Tests When Complete Disease Verification Is Not Feasible
- Testing the Independence of Two Diagnostic Tests
- A general latent class model for performance evaluation of diagnostic tests in the absence of a gold standard: an application to Chagas disease
- Using relative statistics and approximate disease prevalence to compare screening tests
- Inverse probability weighting estimation of the volume under the ROC surface in the presence of verification bias
This page was built for publication: Comparing disease screening tests when true disease status is ascertained only for screen positives
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5701255)
